Elotuzumab and ixazomib join the therapeutic arsenal for multiple myeloma

被引:0
作者
Abraham, Jame
机构
关键词
D O I
10.12788/jcso.0287
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:334 / 336
页数:3
相关论文
共 4 条
  • [1] [Anonymous], NINL IX
  • [2] [Anonymous], EMPL EL
  • [3] Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
    Lonial, Sagar
    Dimopoulos, Meletios
    Palumbo, Antonio
    White, Darrell
    Grosicki, Sebastian
    Spicka, Ivan
    Walter-Croneck, Adam
    Moreau, Philippe
    Mateos, Maria-Victoria
    Magen, Hila
    Belch, Andrew
    Reece, Donna
    Beksac, Meral
    Spencer, Andrew
    Oakervee, Heather
    Orlowski, Robert Z.
    Taniwaki, Masafumi
    Roellig, Christoph
    Einsele, Hermann
    Wu, Ka Lung
    Singhal, Anil
    San-Miguel, Jesus
    Matsumoto, Morio
    Katz, Jessica
    Bleickardt, Eric
    Poulart, Valerie
    Anderson, Kenneth C.
    Richardson, Paul
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (07) : 621 - 631
  • [4] Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Moreau, P.
    Masszi, T.
    Grzasko, N.
    Bahlis, N. J.
    Hansson, M.
    Pour, L.
    Sandhu, I.
    Ganly, P.
    Baker, B. W.
    Jackson, S. R.
    Stoppa, A. -M.
    Simpson, D. R.
    Gimsing, P.
    Palumbo, A.
    Garderet, L.
    Cavo, M.
    Kumar, S.
    Touzeau, C.
    Buadi, F. K.
    Laubach, J. P.
    Berg, D. T.
    Lin, J.
    Di Bacco, A.
    Hui, A. -M.
    van de Velde, H.
    Richardson, P. G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (17) : 1621 - 1634